A long-standing debate in the commercial stem cell arena has focused on whether stem cells grown in a lab prior to clinical use as a transplantation product are biological drugs subject to full FDA vetting. The alternative view has been that such stem cell products are not drugs, but rather are simple human cellular and […]
Court in Regenerative Sciences Case: Propagated Stem Cells Are Drugs Read More »
What can clouds tell us about a stem cell legal court case strategy such as USA v. Regenerative Sciences? It turns out, quite a lot. In about a week a Federal Appeals Court Case will begin to review the ruling in the USA v Regenerative Sciences that favored the FDA. This is arguably one of
USA v Regenerative Sciences Word Clouds are Illuminating Read More »
Regenerative Sciences, Inc. just announced in a press release (PR) that John C. Malone (pictured above in their PR), Ph.D. has “joined the Regenexx Team”. Malone has infused the restive stem cell company with millions in cash. Regenerative Sciences is the adult stem cell company run by Dr. Chris Centeno of the Centeno/Schultz Clinic that is locked in
What are the most significant stem cell and regenerative medicine good news stories of 2024? Since it has been an eventful year, there are many possibilities. Please see our poll at the bottom of this post and weigh in on what you think is the most important encouraging news. If you don’t see your choice
Poll on stem cell & regenerative medicine good news of 2024 Read More »
As we look to 2025, what are the best regenerative medicine and stem cell journals? Is there a stem cell journal list out there? I seem to have the only comprehensive list. Who better than a stem cell biologist to put together this kind of list? Why is this important? Scientists need to know what
List of regenerative medicine & stem cell journals Read More »
Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good
Recent stem cell & regenerative medicine good news Read More »
Here is my 2020 Stem Cell and Regenerative medicine Meetings List. Send me your listings if you don’t see your meeting here. Meeting listings are not endorsements and I try to make this list fairly comprehensive so it may even include some meetings that require a second look before deciding on attending. January Tissue Organoids
2020 Stem Cell & Regenerative Medicine Meetings Read More »
I keep a yearly hub of stem cell & regenerative medicine meetings here on The Niche. Below I’ve pasted the list for 2019, which continues to grow. If you don’t see yours listed, send me an email with the info including a link (knoepflerATucdavisDOTedu). These meeting listings are not endorsements and I try to make
Stem cell & regenerative medicine meetings for you to go to in 2019 Read More »
Below is a list of upcoming stem cell and regenerative medicine conferences and meetings for 2016. You can see the meeting list for 2020 here. The new year has a lot to offer in our field. If you do not see your meeting, please let me know and I will include it. This list is
2016 Stem Cell & Regenerative Medicine Meetings Read More »
IntelliCell BioSciences, Inc. of New York, a clinical stem cell establishment, has had a rough time of it lately. For example, a recent piece of bad news is that there is an impending foreclosure sale of the company’s assets. What exactly that means for the company more broadly remains unknown, but a few people tell me (take this
New FDA IntelliCell BioSciences, Audit Report: A Lot of Work to Do Read More »